Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA

Parallel Session 4- Innate Immunity, xenoantigens and antibodies (Xeno Track)

6.130 - Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion

Presenter: Joshua, Waldman, Toledo, United States
Authors: Joshua Waldman1, Thomas Vogel2, Peter Friend2, Michael Rees1

130

Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion

Joshua Waldman1, Thomas Vogel2, Peter Friend2, Michael Rees1

1Urology, University of Toledo Medical Center, Toledo, MI, United States; 2Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom

Background: Patients in fulminant hepatic failure (FHF) currently do not have a temporary means of support while awaiting liver transplantation. A potential therapeutic approach for patients in FHF is the use of extracorporeal perfusion with porcine livers as a form of “liver dialysis”. During a 72 hour extracorporeal perfusion of porcine livers with human blood, porcine Kupffer cells (KC) bind to and phagocytose human red blood cells (hRBC) causing the hematocrit to decrease to 2.5% of the original value. Our laboratory has identified sialoadhesin (Sn) on the surface of porcine KC as the lectin responsible for binding N-acetylneuraminic acid (Neu5Ac) on the surface of the hRBC. In order for extracorporeal porcine liver perfusion to be used as a therapy for patients in liver failure, all forms of anti-human rejection must be resolved. We evaluated whether targeting Sn prevents the recognition and subsequent destruction of hRBCs seen during extracorporeal porcine liver xenoperfusion.

Methods: Six wild type pig livers were perfused with isolated hRBCs for 72 hours. In one group, three livers were treated with an anti-Sn antibody. As a control group, three livers were treated with an antibody of the same isotype but with no known specificity for Sn.

Results: We have shown that the addition of an anti-Sn antibody to an extracorporeal porcine liver xenoperfusion model significantly reduces the loss of hRBC over a 72 hour period (p <0.01). Sustained liver function was demonstrated by continued bile production and other markers.

Conclusions: This study suggests that the destruction of human erythrocytes in an extracorporeal porcine liver xenoperfusion model is, in part, mediated by Sn expressed on the surface of porcine KC. Furthermore, this data illustrates that the addition of anti-Sn antibody to the circulation of a pig-to-human xenoperfusion may inhibit the destruction of human erythrocytes by porcine Kupffer cells.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada